MAM
EW icon

Morse Asset Management’s Edwards Lifesciences EW Stock Holding History

Morse Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-150
Closed -$13.6K – 402
2026
Q2 		$13.6K Sell
150
-14
-9% -$1.17K ﹤0.01% 309
2026
Q1 		$13.1K Hold
164
– – ﹤0.01% 283
2025
Q4 		$14K Buy
164
+39
+31% +$3.2K ﹤0.01% 269
2025
Q3 		$9.7K Buy
125
+25
+25% +$1.95K ﹤0.01% 268
2025
Q2 		$7.82K Buy
+100
New +$7.46K ﹤0.01% 277

Other funds holding EW

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mirova US
Mirova US Boston, Massachusetts $9.15B AUM 21.91% 1-Year Est. Return

Morse Asset Management's EW Position: Q3 2026 in Review

Morse Asset Management sold out of Edwards Lifesciences (EW) in Q3 2026, closing a stake of 150 shares — an estimated $13.6K sold.

Morse Asset Management first reported a position in EW in Q2 2025 and held it in 5 quarters. The position peaked at $14K in Q4 2025. 827 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Morse Asset Management reported no remaining Edwards Lifesciences position as of Q3 2026 after selling out during the quarter.
  • Morse Asset Management sold 150 Edwards Lifesciences shares in Q3 2026, an estimated $13.6K.
  • Morse Asset Management first reported a position in Edwards Lifesciences in Q2 2025 and held it in 5 quarters.
  • Morse Asset Management's Edwards Lifesciences position peaked at $14K in Q4 2025.
  • 827 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Morse Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.